Finvasia has acquired Gini Health, a Canada based healthcare technology company that pioneered DNA and lifestyle data based personalized health to prevent diseases. This acquisition furthers Finvasia’s strategic business objectives of investing in traditional businesses and transforming them.

Effective immediately, all the previous investors have exited, making Finvasia and Gini Health’s founder and CEO Gurjot Narwal key stakeholders in the company. This move by Finvasia is a  step towards making the company’s capital structure lean, providing them more room to support their business strategy.

Gini Health’s founder and CEO Gurjot Narwal will keep leading the company. Finvasia along with the investment will provide group resources, operational experience, technology, infrastructure, and its reach as a multidisciplinary, multinational organization.

“We’re excited to partner with Gini Health and this investment is a cornerstone of our strategy to fuel our pipeline with healthcare innovation,” said Sarvjeet Singh, Co-founder Finvasia. “Together, we’ll bring tech-driven personalised and long-term health care to people at a time when health is top-of-mind for all of us. This investment executes on Finvasia’s commitment to transform healthcare access and delivery,” he further added.

“Health industry is going through a massive transformation and Gini Health has been leading this with its approach to using health data and technology to empower users to get positive health outcomes,” said Gurjot Narwal, CEO & Founder Gini Health. “Finvasia is a successful conglomerate that harnesses technology to drive innovation and transform industries. Partnering with Finvasia brings two passionate and innovative companies together to accelerate transformation in healthcare at a global level,” he added.